Literature DB >> 34468818

[Oncocytic tumours of the kidney-new differential diagnoses].

I Polifka1, R Ohashi2, H Moch3.   

Abstract

BACKGROUND: Recent developments in differential diagnosis have led to new knowledge about oncocytic renal neoplasms.
OBJECTIVES: Overview of differential diagnosis of oncocytic tumours.
MATERIALS AND METHODS: We performed a literature search on oncocytic renal tumours and mapped known tumour types. Possible differential diagnoses are discussed.
RESULTS: Besides the tumour types already acknowledged by the 2016 WHO classification, there is new evidence regarding the group of hard-to-classify oncocytic neoplasms. Findings point to immunohistochemical and molecular characteristics that may lead to the establishment of new entities in the future. In addition, important differential diagnosis can now be identified, facilitating specific therapies for oncocytic renal tumours.
CONCLUSION: A correct diagnosis of oncocytic renal tumours not only improves prognostic assessment (and, if necessary, specific therapies) but is also clinically relevant regarding a possible association with hereditary tumour syndromes.
© 2021. Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Chromophobe renal cell carcinoma; ESC; MTOR; Oncocytoma; SDH

Mesh:

Year:  2021        PMID: 34468818     DOI: 10.1007/s00292-021-00979-w

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  51 in total

1.  Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status.

Authors:  Chiara Bardella; Mona El-Bahrawy; Norma Frizzell; Julie Adam; Nicola Ternette; Emine Hatipoglu; Kimberley Howarth; Linda O'Flaherty; Ian Roberts; Gareth Turner; Jennifer Taylor; Konstantinos Giaslakiotis; Valentine M Macaulay; Adrian L Harris; Ashish Chandra; Heli J Lehtonen; Virpi Launonen; Lauri A Aaltonen; Christopher W Pugh; Radu Mihai; David Trudgian; Benedikt Kessler; John W Baynes; Peter J Ratcliffe; Ian P Tomlinson; Patrick J Pollard
Journal:  J Pathol       Date:  2011-06-01       Impact factor: 7.996

2.  The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters.

Authors:  Brett Delahunt; John C Cheville; Guido Martignoni; Peter A Humphrey; Cristina Magi-Galluzzi; Jesse McKenney; Lars Egevad; Ferran Algaba; Holger Moch; David J Grignon; Rodolfo Montironi; John R Srigley
Journal:  Am J Surg Pathol       Date:  2013-10       Impact factor: 6.394

3.  The somatic genomic landscape of chromophobe renal cell carcinoma.

Authors:  Caleb F Davis; Christopher J Ricketts; Min Wang; Lixing Yang; Andrew D Cherniack; Hui Shen; Christian Buhay; Hyojin Kang; Sang Cheol Kim; Catherine C Fahey; Kathryn E Hacker; Gyan Bhanot; Dmitry A Gordenin; Andy Chu; Preethi H Gunaratne; Michael Biehl; Sahil Seth; Benny A Kaipparettu; Christopher A Bristow; Lawrence A Donehower; Eric M Wallen; Angela B Smith; Satish K Tickoo; Pheroze Tamboli; Victor Reuter; Laura S Schmidt; James J Hsieh; Toni K Choueiri; A Ari Hakimi; Lynda Chin; Matthew Meyerson; Raju Kucherlapati; Woong-Yang Park; A Gordon Robertson; Peter W Laird; Elizabeth P Henske; David J Kwiatkowski; Peter J Park; Margaret Morgan; Brian Shuch; Donna Muzny; David A Wheeler; W Marston Linehan; Richard A Gibbs; W Kimryn Rathmell; Chad J Creighton
Journal:  Cancer Cell       Date:  2014-08-21       Impact factor: 31.743

4.  Chromophobe renal cell carcinoma: the impact of tumor grade on outcome.

Authors:  John C Cheville; Christine M Lohse; William R Sukov; Robert Houston Thompson; Bradley C Leibovich
Journal:  Am J Surg Pathol       Date:  2012-06       Impact factor: 6.394

5.  Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry.

Authors:  Ying-Bei Chen; A Rose Brannon; Antoun Toubaji; Maria E Dudas; Helen H Won; Hikmat A Al-Ahmadie; Samson W Fine; Anuradha Gopalan; Norma Frizzell; Martin H Voss; Paul Russo; Michael F Berger; Satish K Tickoo; Victor E Reuter
Journal:  Am J Surg Pathol       Date:  2014-05       Impact factor: 6.394

Review 6.  [The translocation carcinoma: A pediatric renal tumor also in adults].

Authors:  E Bruder; H Moch
Journal:  Pathologe       Date:  2016-03       Impact factor: 1.011

7.  [Succinate dehydrogenase (SDH)-deficient renal cell carcinoma].

Authors:  A Agaimy
Journal:  Pathologe       Date:  2016-03       Impact factor: 1.011

8.  Melanotic Xp11 translocation renal cancers: a distinctive neoplasm with overlapping features of PEComa, carcinoma, and melanoma.

Authors:  Pedram Argani; Sebastian Aulmann; Zarir Karanjawala; Robert B Fraser; Marc Ladanyi; Maria M Rodriguez
Journal:  Am J Surg Pathol       Date:  2009-04       Impact factor: 6.394

9.  Somatic Mutations of TSC2 or MTOR Characterize a Morphologically Distinct Subset of Sporadic Renal Cell Carcinoma With Eosinophilic and Vacuolated Cytoplasm.

Authors:  Ying-Bei Chen; Leili Mirsadraei; Gowtham Jayakumaran; Hikmat A Al-Ahmadie; Samson W Fine; Anuradha Gopalan; S Joseph Sirintrapun; Satish K Tickoo; Victor E Reuter
Journal:  Am J Surg Pathol       Date:  2019-01       Impact factor: 6.394

Review 10.  Sarcomatoid Chromophobe Renal Cell Carcinoma: A Case Report and Review of the Literature.

Authors:  Lihui Bian; Jingling Duan; Xiaoyu Wang; Yang Yang; Xiaoling Zhang; Shengjun Xiao
Journal:  Am J Case Rep       Date:  2019-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.